Skip to main content
Molecules logoLink to Molecules
. 2021 Jun 12;26(12):3617. doi: 10.3390/molecules26123617

Facile Synthesis of 2H-Benzo[h]Chromenes via an Arylamine-Catalyzed Mannich Cyclization Cascade Reaction

Yueteng Zhang 1,2,*, Peng Ji 1, Xiang Meng 1, Feng Gao 1, Fanxun Zeng 1, Wei Wang 1,*
Editor: Michal Szostak
PMCID: PMC8231631  PMID: 34204782

Abstract

A simple arylamine-catalyzed Mannich-cyclization cascade reaction was developed for facile synthesis of substituted 2H-benzo[h]chromenes. The notable feature of the process included the efficient generation of ortho-quinone methides (o-QMs) catalyzed by a simple aniline. The mild reaction conditions allowed for a broad spectrum of 1- and 2-naphthols and trans-cinnamaldehydes to engage in the cascade sequence with high efficiency.

Keywords: aminocatalysis, cascade reaction, chromenes, organocatalysis, quinone methide

1. Introduction

2H-Benzo[h]chromenes have attracted considerable attention in recent years due to their applications in medicinal chemistry and drug discovery, optical devices, and molecular imaging [1,2,3,4,5,6]. In particular, they have been extensively studied in photochromism [7,8,9,10]. The structures can undergo ring-opening with a color change via the photochemical cleavage of the sp3 C–O bond. These unique optical properties arise from their reversible changes through irradiation with ultraviolet or visible light with excellent photochromic responses, good colorability, and rapid bleaching. The broad distribution of the naphthopyans in numerous naturally and biologically active compounds [1,2,3,4,5,6], and their predominant applications in optical devices [7,8,9,10], have made the molecular architecture an attractive target for synthesis [2,3].

Along with the classical approaches, significant efforts have been devoted to developing more efficient catalytic methods, largely with transition metals [2,3]. In contrast, there are only a handful of reports about the synthesis of the 2H-benzo[h]chromenes. The methods are dominated by the acid-catalyzed condensation of naphthols with propargylic alcohol by p-toluenesulfonic acid [11,12], acidic alumina [13], indium trichloride [14], and montmorillonite K-10 [15]. Nucleophilic addition dehydration reactions of chromanones with Grignard [16] or organolithium [17] reagents provide an alternative. Cycloaddition reactions of naphthols with simple α, β-unsaturated aldehydes are also attractive strategies. However, the reactions are performed under harsh (refluxing) reaction conditions [18,19,20,21,22]. New methods with mild reaction conditions will streamline the synthesis of 2H-benzo[h]chromenes, which can tolerate broad functional groups. Herein, we wish to document a simple arylamine catalyzed formation of the molecular architectures under mild reaction conditions with a broad substrate scope (Scheme 1). A new reactivity involving the aniline-catalyzed in situ formation of ortho-quinone methide (o-QM) in a catalytic fashion is proposed. The reactivity is harnessed for developing a synthetically powerful Mannich–Diels–Alder cascade manifold for the construction of 2H-benzo[h]chromenes.

Scheme 1.

Scheme 1

Synthesis of 2H-benzo[h]chromenes by Organocatalytic Mannich cyclization cascade reactions via the novel amine-promoted QM pathway.

2. Results and Discussion

2.1. Design Plan

o-QM, a highly reactive intermediate originally harnessed in nature for various biological purposes [23], has been slowly recognized by synthetic organic chemists in organic synthesis [24,25,26,27,28,29]. Given the high reactivity of o-QMs, their in situ formation from the corresponding stable aromatic precursors by temporarily masking the “O” is generally carried out [24,25]. Therefore, an additional activation step is often required. In addition, the synthesis of the precursors is not trivial. We propose a new, more efficient catalytic approach for the in situ generation of o-QMs from readily accessible simple α, β-unsaturated aldehydes (enals) (Scheme 1). We envision that the direct functionalization of the aldehyde group of enals 1 with an amine catalyst gives imine 4. The reaction of 4 with 1-naphthol 2 via a Mannich-type leads to product 5, which serves as a precursor for a subsequent o-QM (6) formation by extrusion of the amine catalyst. Finally, an intramolecular cyclization reaction delivers benzopyrans, driven by re-aromatization.

Although the proposed work looks straightforward on paper, there are several key barriers to overcome for achieving the desired cascade transformations. First, the 1,2-addition reaction (Mannich) of 1 with 1-naphthols 2 may compete with the possible 1,4-conjuage addition process, which has been observed in chiral pyrrolidine-catalyzed Michael cyclization [30]. This suggests that the amine catalysts play key roles in the fate of the products formed. To minimize the 1,4-conjuage addition process, weakly nucleophilic, less-hindered aromatic amines may be the choice of promoters for achieving the desired 1,2-addition. It is believed that the aniline-derived imine 4 favors the 1,2- over 1,4-addition reaction, because its less-electrophilic and more-hindered features reduce the possibility of 1,4-addition, while the less-steric hindrance enhances the 1,2-addition accessibility. Second, achieving an unprecedented catalytic process for the formation of o-QMs is highly appealing but formidably challenging. Precedent studies relied on the preformation of the precursors using a stoichiometric amount of amine, and the generation of o-QMs requires light or acid activation [31,32]. We contemplated that the better leaving tendency of aniline may enable the process in a catalytic manner. The nucleophilicity and leaving tendency of amine need to be balanced to catalyze this cascade process effectively. Due to the better leaving ability of arylamines compared with aliphatic amines, we successfully developed aniline-promoted cyclization replacement cascade reactions of 2-hydroxycinnamaldehydes with various carbonic nucleophiles for the synthesis of dihydrobenzopyrans [33].

2.2. Exploration

To test the possibility of in situ-generated o-QMs promoted by aniline, followed by an intramolecular Diels–Alder reaction, a reaction between trans-cinnamaldehyde (1a) and 1-naphthol (2a) was conducted in the presence of a catalytic amount of an arylamine (20 mol%; Table 1). Gladly, the reaction with 20 mol% of I proceeded to give the desired product 2-phenyl-2H-benzo[h]chromene (3a), albeit a low yield of 10% after 48 h. Encouraged by the results, other anilines containing electron-donating or -withdrawing substituents were probed. 2-Methyoxyaniline (III) was much better than 4-methyoxyaniline (II) (entry 2 vs. 3) for this cascade process, whereas an electron-deficient group like 4-nitroaniline (IV) was less effective (entry 4). Naphthalen-1-amine (V) and a secondary aniline 1,2,3,4-tetrahydroquinoline (VI) were employed, showing an extremely low catalytic potency (entries 5 and 6). Then, we thought about whether ortho-hydrogen-bonding donor groups in the catalyst could accelerate this reaction. Thus, the 2-aminophenol (VII), 2-aminobenzoic acid (VIII) and o-phenylenediamine (IX) aniline analogs were studied (entries 7–9). IX gave the highest yield of 56% (entry 9). Therefore, we chose IX as the choice for further optimization.

Table 1.

Exploration and optimization of the aniline-catalyzed Mannich–Diels–Alder cascade reactions of 1- naphthol (2a) with trans-cinnamaldehyde (1a) a.

graphic file with name molecules-26-03617-i001.jpg

Entry Catalyst Solvent T (°C) t (h) Yield (%) b
1 I CH2Cl2 rt 48 10
2 II CH2Cl2 rt 48 10
3 III CH2Cl2 rt 48 32
4 IV CH2Cl2 rt 48 6
5 V CH2Cl2 rt 48 <5
6 VI CH2Cl2 rt 48 <5
7 VII CH2Cl2 rt 48 <5
8 VIII CH2Cl2 rt 48 <5
9 IX CH2Cl2 rt 48 56
10 IX CH2Cl2 rt 72 56
11 IX CH2Cl2 40 48 57
12 c IX CH2Cl2 rt 48 62
13 d IX CH2Cl2 rt 48 65
14 d IX CH2Cl2 40 16 74
15 d,e IX CH2Cl2 40 17 87
16 d,e,f IX CH2Cl2 40 17 76
17 X CH2Cl2 rt 48 10
18 IX THF rt 48 <5
19 IX Et2O rt 48 13
20 IX MeOH rt 48 <5
21 IX MeCN rt 48 13
22 IX toluene rt 48 54
23 IX ClCH2CH2Cl rt 48 57
24 IX CHCl3 rt 48 50

a Unless stated otherwise, a solution of a catalyst (0.04 mmol), trans- cinnamaldehyde (1a; 0.2 mmol) and 1-naphthol (2a; 0.22 mmol) in CH2Cl2 (1 mL), was stirred at rt for 48 h. The crude mixture was purified via column chromatography. b Isolated yield. c 1.5 equiv. of 2a used. d 1.5 equiv. of 1a used. e Reaction carried out in dry CH2Cl2 under Ar. f 10 mol% IX used.

The solvent effect on the reaction was probed next (Table 1, entries 18–24). Et2O and THF produced low-yielding products (entries 18 and 19). The same happened with polar solvents MeOH and MeCN (entries 20 and 21). This reaction was favored by nonpolar aprotic reaction media (entries 9 and 22–24). Further studies were carried out to optimize the Mannich cyclization cascade reaction in CH2Cl2 with catalyst IX (Table 1). Even though the reaction time was prolonged and the temperature was raised to 40 °C, no further improvement was attended (entries 10 and 11). Increasing the amount of 2a to 1.5 equiv. gave better results (entry 12). When 1-naphthol (2a) was used as a limiting reactant, significant increase in yield (65%) was observed (entry 13). Furthermore, higher temperature, it not only reduced the reaction time but also enhanced the efficiency (entry 14). Finally, when the reaction was performed in dry DCM under Ar atmosphere, the yield was further improved, suggesting a negative effect of water in the reaction (87%, entry 15). A decreased catalyst loading lowered its efficiency (entry 16). Interestingly, p-phenylenediamine (X) gave a very low yield, which indicates that ortho-diamine plays a critical role in catalysis (entry 17). Therefore, the optimal reaction conditions for the formation of 3a involved the usage of 0.3 mmol of 1a, 0.2 mmol of 2a and 20 mol% of IX in 1 mL of dry DCM under Ar.

2.3. Reaction Scope

An investigation was carried out to probe the scope of the reactions of the substituted trans-cinnamaldehyde 1 with 1-naphthol (2) (Scheme 2). It seems the process served as a general approach for the production of structurally diverse 2H-benzo[h]chromenes. The reaction was less sensitive to electronic and steric effects. The enals with electron-withdrawing groups such as nitro, chloro, floro and trifloromethyl all gave rise to good yields (3bd, 3g). A similar trend was observed for trans-cinnamaldehydes bearing electron-donating groups, which furnished 2H-benzo[h]chromenes 3hl in high yields (3hl). The steric demand produced a minimal impact as well (3b, 3f, 3g and 3il). Notably, the mild protocol tolerated various functional groups, such as MeO, hydroxyl, acetoxy, NMe2, etc. Next, we probed the structural variations of 1-napthnols (Scheme 1). The protocol could tolerate electron-withdrawing groups such as Cl, Br, NO2, OMe, NHBoc and NHAc to give the corresponding products 3mr in good yields. Finally, the heteroaromatic enals, including furan, pyridine and quinolone, were examined. They participated in the process to smoothly deliver the desired products 3su with high efficiency.

Scheme 2.

Scheme 2

Scope of the arylamine-catalyzed Mannich–Friedel–Crafts cyclization cascade reactions of substituted trans-cinnamaldehyde (1a) with 1-naphthol (2a) a. a Unless stated otherwise, dry CH2Cl2 (1 mL) was added to the mixture of o-phenylenediamine (0.04 mmol), 1-naphthols (2, 0.20 mmol) and enal (1, 0.30 mmol). After the complete consumption of 1-naphthol, the crude mixture was purified via column chromatography. b isolated yield. c A 50-mg activated 4A MS powder was added. d The reaction was performed at room temperature.

Since 2,2-disubstiuted-2H-chromenes are a common motif in many natural products and bioactive compounds and photochromic molecular devices, we made efforts toward their synthesis using this approach (Scheme 3). Gladly, 2,2-dimethyl-2H-benzo[h]chromene 3v was synthesized with a good yield of 61%. Similarly, when 3,3-diphenylacrylaldehyde was served as a substrate, the corresponding product 3w was obtained with a 78% yield. To further explore the versatility of this new synthetic strategy, reactions by employing 2-naphthols with enal 1 were performed. Both processes ran smoothly with good yields (3x and 3y). When 1,5-dihydroxynaphthalene was served as a substrate, a bis-cyclized product 3,9-diphenyl-3,9-dihydrochromeno[8,7-h]chromene (3z) was formed efficiently in a one-pot operation. Polyhydroxy resorcinol also led to the bis product 2,8-diphenyl-2H,8H-pyrano[2,3-f]chromene (3ab) in a good yield of 60% in a sealed tube at 60 °C. In contrast, when 2,7-dihydroxynaphthalene (2v), which also has two reaction sites, was employed, only mono-product 3aa was formed with an excellent yield of 95%. Finally, the method was demonstrated as a powerful approach for the efficient synthesis of natural product lapachenole (3ac) [34].

Scheme 3.

Scheme 3

Arylamine IX-catalyzed Mannich cyclization cascade reactions of structurally diverse enals with arylols.

3. Materials and Methods

All commercially available reagents were purchased from Sigma-Aldrich, TCI, Alfa, Ambeed in the US and were used without further purification. All reactions were carried out in dried flasks. The progress of the reactions was monitored by analytical thin-layer chromatography (TLC) on Whatman silica gel plates with a fluorescence F254 indicator. Merck 60 silica gel was used for chromatography. 1H (300 MHz) and 13C (75 MHz) NMR spectra were recorded on a Bruker Avance 300 (Supplementary Materials). When deuterated chloroform (CDCl3) was used, residue chloroform was used as an internal reference. When deuterated dimethyl sulfoxide (DMSO) was used, residue dimethyl sulfoxide was used as an internal reference. Data for 1H NMR were reported as follows: chemical shift (ppm) and multiplicity (s = singlet, d = doublet, t = triplet, q = quartet and m = multiplet). Chemical shift for 13C NMR was reported as ppm.

4. General Procedure for the Synthesis of 2H-Benzo[h]Chromene 3

Dry CH2Cl2 (1.0 mL) was added to a mixture of o-phenylenediamine (IX, 0.04 mmol), enal 1 (0.30 mmol) and arylol 2 (0.20 mmol) under Ar. The reaction was stirred at 40 °C until the completion of 2 monitored by TLC. Then, the mixture was applied to column chromatography directly and eluted with ethyl ether and hexane (9/1) to give product 3.

2-Phenyl-2H-benzo[h]chromenes (3a). The title compound was prepared according to the general procedure: 17 h, red oil; 87% yield. 1H NMR (300 MHz, CDCl3) δ (ppm) 8.27–8.24 (m, 1H), 7.81–7.76 (m, 1H), 7.60–7.56 (m, 2H), 7.48–7.39 (m, 6H), 7.22 (d, J = 8.4 Hz, 1H), 6.70 (dd, J = 9.8, 1.7 Hz, 1H), 6.18 (dd, J = 3.6, 1.7 Hz, 1H), 5.92 (dd, J = 9.8, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 148.65, 141.21, 134.74, 128.73, 128.35, 127.71, 126.86, 126.41, 125.56, 124.71, 124.64, 123.39, 122.11, 120.51, 115.80, 77.34. HRMS (ESI) calcd for [C19H14O + H]+: 259.1123, found: 259.1128.

2-(2-Nitrophenyl)-2H-benzo[h]chromene (3b). The title compound was prepared according to the general procedure: 19 h, orange oil; 72% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.15–8.11 (m, 1H), 8.02 (dd, J = 8.1, 1.2 Hz, 1H), 7.87 (dd, J = 7.9, 1.2 Hz, 1H), 7.79–7.74 (m, 1H), 7.56 (td, J = 7.5, 1.2 Hz, 1H), 7.48–7.39 (m, 4H), 7.17 (d, J = 8.4 Hz, 1H), 6.84 (dd, J = 3.6, 1.8 Hz, 1H), 6.66 (dd, J = 9.9, 1.8 Hz, 1H), 5.92 (dd, J = 9.9, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 148.40, 147.09, 136.89, 134.84, 133.82, 128.91, 128.86, 127.82, 126.66, 125.90, 125.13, 124.87, 124.79, 124.28, 121.86, 121.78, 121.03, 115.27, 73.24. HRMS (ESI) calcd for [C19H13NO3 + H]+: 304.0974, found: 304.0971.

2-(4-Nitrophenyl)-2H-benzo[h]chromene (3c). The title compound was prepared according to the general procedure except that 50 mg 4 Å MS powder was added: 60 h, orange oil; 83% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.21–8.16 (m, 3H), 7.78–7.72 (m, 1H), 7.66 (d, J = 8.7 Hz, 2H), 7.49–7.39 (m, 3H), 7.17 (d, J = 8.4 Hz, 1H), 6.71 (dd, J = 9.9, 1.8 Hz, 1H), 6.19 (dd, J = 3.9, 1.8 Hz 1H), 5.88 (dd, J = 9.9, 3.9 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 148.16, 148.08, 147.81, 134.86, 127.88, 127.35, 126.76, 125.97, 125.61, 124.65, 124.44, 124.00, 121.82, 121.75, 121.18, 115.67, 75.93. HRMS (ESI) calcd for [C19H13NO3 + H]+: 304.0974, found: 304.0969.

2-(4-Fluorophenyl)-2H-benzo[h]chromene (3d). The title compound was prepared according to the general procedure: 46 h; red oil; 83% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.18–8.15 (m, 1H), 7.76–7.73 (m, 1H), 7.53–7.48 (m, 2H), 7.46–7.37 (m, 3H), 7.18 (d, J = 8.1 Hz, 1H), 7.09–7.02 (m, 2H), 6.69 (dd, J = 9.9, 1.8 Hz, 1H), 6.11 (d, J = 2.4 Hz, 1H), 5.86 (dd, J = 9.6, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 162.82 (d, J = 245 Hz), 148.38, 136.87, 134.76, 128.91, 128.80, 127.76, 126.50, 125.65, 124.96, 124.68, 123.02, 122.00, 120.66, 115.76, 115.48, 76.58. HRMS (ESI) calcd for [C19H13FO + H]+: 277.1029, found: 277.1032.

2-(4-Chlorophenyl)-2H-benzo[h]chromene (3e). The title compound was prepared according to the general procedure: 17 h; red oil; 81% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.21–8.16 (m, 1H), 7.78–7.74 (m, 1H), 7.49–7.39 (m, 5H), 7.36–7.32 (m, 2H), 7.19 (d, J = 8.4 Hz, 1H), 6.69 (dd, J = 9.9, 1.8 Hz, 1H), 6.10 (dd, J = 3.9, 1.8 Hz, 1H), 5.85 (dd, J = 9.9, 3.9 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 148.32, 139.55, 134.75, 134.21, 128.90, 128.33, 127.77, 126.53, 125.70, 125.03, 124.67, 124.60, 122.75, 121.95, 120.73, 115.74, 76.44. HRMS (ESI) calcd for [C19H13ClO + H]+: 293.0733, found: 293.0736.

2-(2-Bromophenyl)-2H-benzo[h]chromene (3f). The title compound was prepared according to the general procedure: 66 h; red oil; 85% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.24–8.19 (m, 1H), 7.79–7.74 (m, 1H), 7.66–7.62 (m, 2H), 7.48–7.39 (m, 3H), 7.29 (td, J = 7.5, 0.9 Hz, 1H), 7.19 (d, J = 8.1 Hz, 2H), 6.68 (dd, J = 9.9, 1.8 Hz, 1H), 6.53 (dd, J = 3.6, 1.8 Hz, 1H), 5.91 (dd, J = 9.9, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 148.68, 140.00, 134.78, 133.18, 129.75, 128.92, 127.93, 127.72, 126.53, 125.71, 124.97, 124.69, 124.54, 122.19, 122.14, 121.85, 120.70, 115.50, 76.46. HRMS (ESI) calcd for [C19H13BrO + H]+: 337.0228, found: 337.0224.

2-(2-(Trifluoromethyl)phenyl)-2H-benzo[h]chromene (3g). The title compound was prepared according to the general procedure: 42 h, red oil; 71% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.15–8.12 (m, 1H), 7.95 (d, J = 7.8 Hz, 1H), 7.78–7.75 (m, 2H), 7.55 (t, J = 7.5 Hz, 1H), 7.47–7.39 (m, 4H), 7.21 (d, J = 8.4 Hz, 1H), 6.66 (dd, J = 9.6, 1.8 Hz, 1H), 6.61 (s, 1H), 5.75 (dd, J = 9.9, 3.3 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 148.59, 139.92, 134.89, 132.57, 129.64, 128.43, 127.71, 126.74 (q, J = 30 Hz), 126.59, 125.97 (q, J = 2.1 Hz), 125.68, 124.69, 124.65, 123.03, 122.14, 120.74, 115.10, 73.71. HRMS (ESI) calcd for [C20H13F3O + H]+: 327.0997, found: 327.0999.

2-(4-Methoxyphenyl)-2H-benzo[h]chromene (3h). The title compound was prepared according to the general procedure: 17 h; red oil; 84% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.20–8.17 (m, 1H), 7.76–7.72 (m, 1H), 7.49–7.37 (m, 5H), 7.19 (d, J = 8.4 Hz,1H), 6.93–6.88 (m, 2H), 6.69 (dd, J = 9.8, 1.8 Hz, 1H), 6.10 (dd, J = 3.9, 1.8 Hz, 1H), 5.88 (dd, J = 9.8, 3.6 Hz, 1H), 3.79 (s, 3H). 13C NMR (75 MHz, CDCl3) δ (ppm) 159.82, 148.58, 134.73, 133.23, 128.56, 127.68, 126.35, 125.48, 124.76, 124.67, 123.44, 122.13, 120.39, 115.85, 114.11, 77.02, 55.36. HRMS (ESI) calcd for [C20H16O2 + H]+: 289.1229, found: 289.1235.

2-(2-Methoxyphenyl)-2H-benzo[h]chromene (3i). The title compound was prepared according to the general procedure: 24 h; red oil; 80% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.22–8.18 (m, 1H), 7.76–7.53 (m, 1H), 7.51 (dd, J = 7.5, 1.5 Hz, 1H), 7.45–7.39 (m, 2H), 7.37 (d, J = 8.1 Hz, 1H), 7.31–7.25 (m, 1H), 7.16 (d, J = 8.4 Hz, 1H), 6.95–6.89 (m, 2H), 6.58 (dd, J = 9.6, 1.8 Hz, 1H), 6.53 (dd, J = 3.6, 1.8 Hz, 1H), 5.90 (dd, J = 9.9, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 155.82, 149.02, 134.71, 129.81, 129.14, 127.73, 127.52, 126.28, 125.50, 124.80, 124.62, 123.78, 123.73, 122.16, 120.94, 120.31, 115.66, 110.70, 72.54, 55.65. HRMS (ESI) calcd for [C20H16O2 + H]+: 289.1229, found: 289.1230.

4-(2H-Benzo[h]chromen-2-yl)-N,N-dimethylaniline (3j). The title compound was prepared according to the general procedure, except that the mixture was stirred at room temperature: 36 h; purple oil; 54% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.18–8.14 (m, 1H), 7.3–7.70 (m, 1H), 7.43–7.33 (m, 5H), 7.18 (d, J = 8.4 Hz, 1H), 6.73–6.66 (m, 3H), 6.06 (dd, J = 3.9, 1.8 Hz, 1H), 5.87 (dd, J = 9.6, 3.6 Hz, 1H), 2.94 (s, 6H). 13C NMR (75 MHz, CDCl3) δ (ppm) 150.80, 148.73, 134.65, 128.56, 128.48, 127.61, 126.22, 125.33, 124.84, 124.72, 124.43, 123.73, 122.27, 120.13, 115.92, 112.43, 77.41, 40.59. HRMS (ESI) calcd for [C21H19NO + H]+: 302.1545, found: 302.1544.

4-(2H-Benzo[h]chromen-2-yl)-2-methoxyphenyl acetate (3k). The title compound was prepared according to the general procedure: 46 h; red oil; 99% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.20–8.17 (m, 1H), 7.75–7.72 (m, 1H), 7.44–7.36 (m, 3H), 7.19–7.16 (m, 2H), 7.10–7.00 (m, 2H), 6.66 (dd, J = 9.9, 1.8 Hz, 1H), 6.10 (dd, J = 3.6, 1.8 Hz, 1H), 5.87 (dd, J = 9.6, 3.6 Hz, 1H), 3.79 (s, 3H), 2.31 (s, 3H). 13C NMR (75 MHz, CDCl3) δ (ppm) 169.15, 151.28, 148.54, 140.16, 139.70, 134.76, 127.78, 126.50, 125.67, 124.91, 124.68, 124.62, 123.25, 122.93, 122.01, 120.71, 119.16, 115.85, 111.09, 76.97, 55.99, 20.81. HRMS (ESI) calcd for [C22H18O4 + H]+: 347.1283, found: 347.1283.

4-(2H-benzo[h]chromen-2-yl)-2-methoxyphenol (3l). The title compound was prepared according to the general procedure: 68 h; red oil; 77% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.19–8.16 (m, 1H), 7.76–7.72 (m, 1H), 7.45–7.36 (m, 3H), 7.19 (d, J = 8.1 Hz, 1H), 7.09–7.01 (m, 2H), 6.91 (d, J = 8.1 Hz, 1H), 6.68 (dd, J = 9.9, 1.8 Hz, 1H), 6.06 (dd, J = 3.3, 1.5 Hz, 1H), 5.87 (dd, J = 9.9, 3.6 Hz, 1H), 5.68 (s, 1H), 3.84 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 148.56, 146.69, 145.90, 134.70, 133.05, 127.71, 126.38, 125.50, 124.79, 124.67, 123.53, 122.06, 120.46, 120.42, 115.88, 114.39, 109.82, 77.32, 55.99. HRMS (ESI) calcd for [C20H16O3 + H]+: 305.1178, found: 305.1177.

6-Chloro-2-phenyl-2H-benzo[h]chromene (3m). The title compound was prepared according to the general procedure: 46 h; red oil; 81% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 1H NMR (300 MHz, CDCl3) δ 8.22–8.13 (m, 2H), 7.57–7.45 (m, 5H), 7.41–7.33 (m, 3H), 7.29 (s, 1H), 6.60 (dd, J = 9.9, 1.8 Hz, 1H), 6.13 (dd, J = 3.6, 1.8 Hz, 1H), 5.91 (dd, J = 9.9, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 147.64, 140.68, 131.40, 128.81, 128.58, 127.47, 126.93, 126.29, 125.74, 124.48, 124.17, 123.75, 123.43, 122.47, 116.09, 77.46. HRMS (ESI) calcd for [C19H13ClO + H]+: 293.0733, found: 293.0735.

6-Bromo-2-phenyl-2H-benzo[h]chromene (3n). The title compound was prepared according to the general procedure, except that 50-mg 4Å MS powder was added: 72 h; red oil; 60% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.21–8.09 (m, 2H), 7.57–7.43 (m, 5H), 7.41–7.30 (m, 3H), 6.60 (dd, J = 9.9, 1.5 Hz, 1H), 6.14 (dd, J = 3.3, 1.5 Hz, 1H), 5.90 (dd, J = 9.6, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 148.34, 140.66, 132.57, 128.83, 128.60, 128.09, 127.76, 127.13, 126.94, 126.31, 125.93, 124.15, 123.62, 122.49, 116.73, 113.45, 77.50. HRMS (ESI) calcd for [C19H13BrO + H]+: 337.0228, found: 337.0232.

6-Nitro-2-phenyl-2H-benzo[h]chromene (3o). The title compound was prepared according to the general procedure, except that 50-mg 4Å MS powder was added: 72 h; red oil; 62% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.74 (d, J = 8.7 Hz, 1H), 8.24 (d, J = 8.7 Hz, 1H), 8.18 (s, 1H), 7.68–7.52(m, 1H), 7.52–7.47(m, 3H), 7.43–7.33(m, 3H), 6.65 (dd, J = 9.9, 1.5 Hz, 1H), 6.26 (dd, J = 3.3, 1.5 Hz, 1H), 5.96 (dd, J = 9.9, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 154.19, 139.86, 138.92, 130.26, 129.02, 127.18, 127.10, 126.76, 125.01, 124.67, 124.56, 123.74, 122.78, 122.73, 113.63, 78.85. HRMS (ESI) calcd for [C19H13NO3 + H]+: 304.0974, found: 304.0975.

6-Methoxy-2-phenyl-2H-benzo[h]chromene (3p). The title compound was prepared according to the general procedure: 26 h; red oil; 60% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.19–8.16 (m, 2H), 7.51–7.53 (m, 2H), 7.50– 7.32 (m, 5H), 6.64 (dd, J = 9.9, 1.8 Hz, 1H), 6.54 (s, 1H), 6.07 (dd, J = 3.6, 1.5 Hz, 1H), 5.93 (dd, J = 9.9, 3.9 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 149.77, 142.45, 141.21, 128.68, 128.26, 126.84, 126.34, 126.27, 125.81, 125.48, 125.05, 123.92, 122.02, 121.84, 115.39, 102.64,76.86, 55.88. HRMS (ESI) calcd for [C20H16O2 + H]+: 289.1229, found: 289.1233.

tert-Butyl (2-phenyl-2H-benzo[h]chromen-6-yl)carbamate (3q). The title compound was prepared according to the general procedure: 41 h; red oil; 81% yield; 1H NMR (300 MHz, CDCl3) δ 7.99 (d, J = 8.4 Hz, 1H), 7.84 (d, J = 7.5 Hz, 1H), 7.52–7.50 (m, 2H), 7.41–7.32 (m, 5H), 7.18 (d, J = 8.4 Hz, 1H), 6.81 (s, 1H), 6.64 (dd, J = 9.6, 1.5 Hz, 1H), 6.13 (dd, J = 3.3, 1.2 Hz, 1H), 5.90 (dd, J = 9.9, 3.9 Hz, 1H), 1.57 (s, 11H). 13C NMR (75 MHz, CDCl3) δ (ppm) 153.60, 149.11, 141.01, 132.92, 128.75, 128.41, 127.69, 126.81, 125.51, 125.33, 124.72, 124.26, 123.78, 119.35, 118.52, 115.84, 113.01, 80.75, 77.39, 28.50. HRMS (ESI) calcd for [C24H23NO3 + H]+: 374.1756, found: 374.1753.

N-(2-Phenyl-2H-benzo[h]chromen-6-yl)acetamide (3r). The title compound was prepared according to the general procedure: 72 h; red oil; 95% yield; 1H NMR (300 MHz, DMSO) δ (ppm) 9.84 (s, 1H), 7.90 (d, J = 8.1 Hz, 1H), 7.66–7.59 (m, 2H), 7.50–7.31 (m, 7H), 6.79 (d, J = 9.6 Hz, 1H), 6.23 (d, J = 3.3 Hz, 1H), 6.11 (dd, J = 9.6, 3.9 Hz, 1H), 2.17 (s, 3H). 13C NMR (75 MHz, DMSO) δ (ppm) 168.84, 147.59, 140.68, 133.77, 128.18, 128.55, 126.37, 125.32, 124.53, 124.32, 124.23, 123.52, 121.99, 118.26, 115.75, 115.22, 75.97, 23.45. HRMS (ESI) calcd for [C21H17NO2 + H]+: 316.1338, found: 316.1340.

2-(Furan-2-yl)-2H-benzo[h]chromene (3s). The title compound was prepared according to the general procedure, except that the mixture was stirred at room temperature: 24 h; red oil; 51% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.21–8.18 (m, 1H), 7.74–7.70 (m, 1H), 7.45–7.36 (m, 4H), 7.19 (d, J = 8.4 Hz, 1H), 6.74 (dd, J = 9.6, 1.2 Hz, 1H), 6.41 (d, J = 3.0 Hz, 1H), 6.30 (dd, J = 2.7, 1.8 Hz, 1H), 6.14 (d, J = 3.3 Hz, 1H), 5.89 (dd, J = 9.6, 4.2 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 152.88, 148.20, 143.40, 134.67, 127.65, 126.45, 126.07, 125.57, 124.82, 124.69, 122.16, 120.72, 119.85, 115.88, 110.47, 109.55, 70.04. HRMS (ESI) calcd for [C17H12O2 + H]+: 249.0916, found: 249.0918.

3-(2H-Benzo[h]chromen-2-yl)-2-bromopyridine (3t). The title compound was prepared according to the general procedure: 24 h; red oil; 80% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.31 (dd, J = 4.8, 2.1 Hz, 1H), 8.17 (dd, J = 6.0, 3.6 Hz, 1H), 7.87 (dd, J = 7.8, 1.8 Hz, 1H), 7.76–7.33 (m, 1H), 7.46–7.39 (m, 3H), 7.23–7.16 (m, 2H), 6.70 (dd, J = 9.9, 1.8 Hz, 1H), 6.43 (dd, J = 3.6, 1.8 Hz, 1H), 5.90 (dd, J = 9.6, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 149.66, 148.23, 141.44, 137.22, 137.13, 134.83, 127.78, 126.73, 125.92, 125.61, 124.60, 124.37, 123.34, 121.96, 121.10, 120.95, 115.37, 75.38. HRMS (ESI) calcd for [C18H12BrNO + H]+: 338.0181, found: 338.0180.

4-(2H-Benzo[h]chromen-2-yl)isoquinoline (3u). The title compound was prepared according to the general procedure: 24 h; red oil; 91% yield; 1H NMR (300 MHz, CDCl3) δ 8.90 (d, J = 4.5 Hz, 1H), 8.27 (d, J = 8.4 Hz, 1H), 8.19 (d, J = 8.4 Hz, 1H), 8.12–8.09 (m, 1H), 7.77–7.73 (m, 2H), 7.68–7.60 (m, 2H), 7.45–7.36 (m, 3H), 7.21 (d, J = 8.4 Hz, 1H), 6.80–6.74 (m, 2H), 5.91 (dd, J = 9.6, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 150.55 (s), 148.76, 148.64, 145.01, 134.86, 130.57, 129.40, 127.80, 127.10, 126.70, 126.14, 125.88, 125.61, 124.70, 124.52, 123.62, 121.99, 121.51, 121.17, 119.23, 115.75, 73.67. HRMS (ESI) calcd for [C22H15NO + H]+: 310.1232, found: 310.1236.

2,2-Dimethyl-2H-benzo[h]chromene (3v). The title compound was prepared according to the general procedure, except that 50-mg 4 Å MS powder was added: 72 h; colorless oil; 61% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.24–8.21 (m, 1H), 7.76–7.73 (m, 1H), 7.48–7.43 (m, 2H), 7.35 (d, J = 8.4 Hz, 1H), 7.16 (d, J = 8.4 Hz, 1H), 6.46 (d, J = 9.6 Hz, 1H), 5.65 (d, J = 9.6 Hz, 1H), 1.54 (s, 6H). 13C NMR (75 MHz, CDCl3) δ (ppm) 148.20, 134.40, 129.26, 127.52, 126.04, 125.17, 125.03, 124.49, 122.77, 121.93, 119.78, 115.33, 76.75, 27.93. HRMS (ESI) calcd for [C15H14O + H]+: 211.1123, found: 211.1121.

2,2-Diphenyl-2H-benzo[h]chromene (3w). The title compound was prepared according to the general procedure, except that 50-mg 4 Å MS powder was added: 34 h; red oil; 78% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.44 (d, J = 7.2 Hz, 1H), 7.77 (d, J = 8.1 Hz, 1H), 7.61–7.46 (m, 6H), 7.40–7.26 (m, 7H), 7.21 (d, J = 8.1 Hz, 1H), 6.78 (d, J = 9.6 Hz, 1H), 6.25 (d, J = 9.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 147.70, 145.16, 134.63, 128.12, 127.63, 127.45, 127.25, 126.82, 126.27, 125.54, 124.67, 124.50, 123.83, 121.98, 120.46, 115.42, 83.16. HRMS (ESI) calcd for [C25H18O + H]+: 335.1436, found: 335.1436.

3-Phenyl-3H-benzo[f]chromene (3x). The title compound was prepared according to the general procedure, except that 50-mg 4 Å MS powder was added: 6 days; white solid; 68% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.00 (d, J = 9.0 Hz, 1H), 7.76 (d, J = 9.0 Hz, 1H), 7.67 (d, J = 9.0 Hz, 1H), 7.54–7.48 (m, 3H), 7.42–7.26 (m, 4H), 7.29–7.26 (m, 1H), 7.10 (d, J = 9.0 Hz, 1H), 6.01–5.94 (m, 2H). 13C NMR (75 MHz, CDCl3) δ (ppm) 151.47, 140.76, 130.03, 129.87, 129.53, 128.79, 128.72, 128.56, 127.25, 126.83, 123.75, 123.61, 121.41, 120.42, 118.15, 114.29, 77.07. HRMS (ESI) calcd for [C19H14O + H]+: 259.1123, found: 259.1127.

8-Bromo-3-phenyl-3H-benzo[f]chromene (3y). The title compound was prepared according to the general procedure, except that 50-mg 4 Å MS powder was added: 5 days; white solid; 60% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 7.89 (d, J = 1.5 Hz, 1H), 7.83 (d, J = 9.0 Hz, 1H), 7.56–7.50 (m, 4H), 7.42–7.34 (m, 3H), 7.18 (d, J = 9.6 Hz, 1H), 7.09 (d, J = 8.7 Hz, 1H), 6.01–5.94 (m, 2H). 13C NMR (75 MHz, CDCl3) δ (ppm) 151.65, 140.47, 130.63, 130.57, 129.97, 128.84, 128.68, 128.50, 127.23, 124.17, 123.25, 119.96, 119.25, 117.43, 114.43, 77.16. HRMS (ESI) calcd for [C19H13BrO + H]+: 337.0228, found: 337.0229.

3,9-Diphenyl-3,9-dihydrochromeno[8,7-h]chromene (3z). The title compound was prepared according to the general procedure, except that 50-mg 4 Å MS powder was added: 5 days; red oil; 51% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 7.73 (dd, J = 8.4, 1.2 Hz, 2H), 7.55–7.52 (m, 4H), 7.42–7.30 (m, 6H), 7.12 (d, J = 9.0 Hz, 2H), 6.64 (dd, J = 9.6, 1.5 Hz, 2H), 6.14–6.10 (m, 2H), 5.88 (ddd, J = 9.6, 3.6, 2.4 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ (ppm) 148.50, 141.19, 128.73, 128.34, 126.85, 125.60, 124.62, 124.30, 123.63, 123.55, 116.38, 116.30, 114.68, 77.29. HRMS (ESI) calcd for [C28H20O2 + H]+: 389.1542, found: 389.1545.

3-Phenyl-3H-benzo[f]chromen-9-ol (3aa). The title compound was prepared according to the general procedure, except that 50-mg 4 Å MS powder was added: 60 h; orange solid; 95% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 7.62 (d, J = 8.7 Hz, 1H), 7.55 (d, J = 8.7 Hz, 1H), 7.50 (d, J = 6.9 Hz, 2H), 7.39–7.35 (m, 3H), 7.32–7.28 (m, 2H), 7.05 (d, J = 9.9 Hz, 1H), 6.97–6.90 (m, 2H), 5.94 (s, 1H), 5.87 (dd, J = 9.9, 3.0 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ (ppm) 154.92, 152.28, 140.92, 130.79, 129.92, 128.92, 128.69, 127.39, 125.08, 123.17, 120.60, 115.82, 115.63, 113.33, 104.31, 77.16. HRMS (ESI) calcd for [C19H14O2 + H]+: 275.1072, found: 275.1074.

2,8-Diphenyl-2H,8H-pyrano[2,3-f]chromene (3ab). The title compound was prepared according to the general procedure, except that the mixture was heated at 60 °C in sealed tubed with 50-mg 4 Å MS powder: 5 days; orange solid; 60% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 7.53–7.35 (m, 10H), 6.92–6.88 (m, 1H), 6.82 (dd, J = 8.1, 2.1 Hz, 1H), 6.52–6.48 (m, 1H), 6.41 (ddd, J = 8.1, 2.4, 0.6 Hz, 1H), 5.97 (dd, J = 3.3, 1.8 Hz, 1H), 5.90–5.87 (m, 1H), 5.80–5.71 (m, 2H). 13C NMR (75 MHz, CDCl3) δ (ppm) 154.04, 148.86, 148.79, 140.94, 140.65, 140.58, 128.56, 128.29, 128.19, 127.05, 127.03, 126.79, 123.96, 123.87, 123.33, 123.20, 121.75, 121.60, 118.45, 118.29, 115.03, 114.92, 109.98, 109.88, 108.53, 77.07, 76.88. HRMS (ESI) calcd for [C24H18O2 + H]+: 339.1385, found: 339.1384.

6-Methoxy-2,2-dimethyl-2H-benzo[h]chromene (3ac). The title compound was prepared according to the general procedure, with 50-mg 4Å MS powder added: 60 h; colorless; 56% yield; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.16 (d, J = 8.1 Hz, 2H), 7.51–7.41 (m, 2H), 6.52 (s, 1H), 6.41 (d, J = 9.6 Hz, 1H), 5.66 (d, J = 9.6 Hz, 1H), 3.96 (s, 3H), 1.51 (s, 6H). 13C NMR (75 MHz, CDCl3) δ (ppm) 149.42, 142.08, 130.04, 126.19, 126.04, 125.59, 123.19, 121.97, 121.83, 114.90, 102.69, 76.33, 55.92, 27.70. HRMS (ESI) calcd for [C16H16O2 + H]+: 241.1229, found: 241.1233.

5. Conclusions

In conclusion, we designed and realized a simple arylamine-catalyzed Mannich cyclization cascade via in situ-generated o-QMs to the formation of substituted 2H-benzo[h]chromenes. The notable features of the process included the generation of o-QMs catalyzed by a simple aniline for the first time. The mild reaction conditions allowed for a broad spectrum of 1- and 2-napthols and trans-cinnamaldehydes to engage in the cascade sequence with high efficiency. The development of enantioselective cascade reactions for the formation of enantioenriched 2H-benzo[h]chromenes and expansion of the application of a new catalytic strategy in synthesis are being pursued in our laboratories.

Supplementary Materials

The following are available online. The original 1H and 13C NMR spectra are available in supplementary material.

Author Contributions

Manuscript conception, Y.Z. and W.W.; writing—original draft preparation, Y.Z. and W.W.; synthesis of the derivatives, Y.Z., P.J., X.M., F.G. and F.Z. and compound characterization, Y.Z., P.J., X.M., F.G. and F.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (21738002) and the University of Arizona.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data of the compounds are available from the authors.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are not available from the authors.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Schweizer E.E.M.-N., O. Chromenes, Chromanes, Chromones. Volume 31 Wiley-Interscience; New York, NY, USA: 1977. [Google Scholar]
  • 2.Pratap R., Ram V.J. ChemInform Abstract: Natural and Synthetic Chromenes, Fused Chromenes, and Versatility of Dihydrobenzo[h]chromenes in Organic Synthesis. Chemin- 2015;46:10476–10526. doi: 10.1002/chin.201503281. [DOI] [PubMed] [Google Scholar]
  • 3.Majumdar N., Paul N.D., Mandal S., De Bruin B., Wulff W.D. Catalytic Synthesis of 2H-Chromenes. ACS Catal. 2015;5:2329–2366. doi: 10.1021/acscatal.5b00026. [DOI] [Google Scholar]
  • 4.Irie M. Diarylethenes for Memories and Switches. Chem. Rev. 2000;100:1685–1716. doi: 10.1021/cr980069d. [DOI] [PubMed] [Google Scholar]
  • 5.Tian H., Yang S. Recent progresses on diarylethene based photochromic switches. Chem. Soc. Rev. 2004;33:85–97. doi: 10.1039/b302356g. [DOI] [PubMed] [Google Scholar]
  • 6.Samachetty H.D., Branda N.R. Integrating molecular switching and chemical reactivity using photoresponsive hexatrienes. Pure Appl. Chem. 2006;78:2351–2359. doi: 10.1351/pac200678122351. [DOI] [Google Scholar]
  • 7.Lokshin V., Samat A., Metelitsa A.V. Spirooxazines: synthesis, structure, spectral and photochromic properties. Russ. Chem. Rev. 2002;71:893–916. doi: 10.1070/RC2002v071n11ABEH000763. [DOI] [Google Scholar]
  • 8.Di Nunzio M.R., Gentili P.L., Romani A., Favaro G. Photochromic, Thermochromic, and Fluorescent Spirooxazines and Naphthopyrans: A Spectrokinetic and Thermodynamic Study. ChemPhysChem. 2008;9:768–775. doi: 10.1002/cphc.200700789. [DOI] [PubMed] [Google Scholar]
  • 9.Crano J.C., Flood T., Knowles D., Kumar A., Gemert B.V. Photochromic compounds: Chemistry and application in oph-thalmic lenses. Pure Appl. Chem. 1996;68:1395–1398. doi: 10.1351/pac199668071395. [DOI] [Google Scholar]
  • 10.Song L., Yang Y., Zhang Q., Tian H., Zhu W. Synthesis and Photochromism of Naphthopyrans Bearing Naphthalimide Chromophore: Predominant Thermal Reversibility in Color-Fading and Fluorescence Switch. J. Phys. Chem. B. 2011;115:14648–14658. doi: 10.1021/jp208082w. [DOI] [PubMed] [Google Scholar]
  • 11.Tanaka K., Aoki H., Hosomi H., Ohba S. One-Pot Synthesis of Photochromic Naphthopyrans in the Solid State. Org. Lett. 2000;2:2133–2134. doi: 10.1021/ol006038y. [DOI] [PubMed] [Google Scholar]
  • 12.Zhao W., Carreira E.M. Facile One-Pot Synthesis of Photochromic Pyrans. Org. Lett. 2003;5:4153–4154. doi: 10.1021/ol035599x. [DOI] [PubMed] [Google Scholar]
  • 13.Gabbutt C.D., Heron B.M., Instone A.C. The synthesis and electronic absorption spectra of 3-phenyl-3(4-pyrrolidino-2-substituted phenyl)-3H-naphtho[2,1-b]pyrans: further exploration of the ortho substituent effect. Tetrahedron. 2006;62:737–745. doi: 10.1016/j.tet.2005.09.143. [DOI] [Google Scholar]
  • 14.Dong Y.-W., Wang G.-W., Wang L. Solvent-free synthesis of naphthopyrans under ball-milling conditions. Tetrahedron. 2008;64:10148–10154. doi: 10.1016/j.tet.2008.08.047. [DOI] [Google Scholar]
  • 15.Hosseinzadeh R., Mohadjerani M., Ardestanian M.J., Naimi-Jamal M.R., Lasemi Z. Convenient synthesis of naphthopyrans using montmorillonite K-10 as heterogeneous catalyst. J. Chem. Sci. 2014;126:1081–1089. doi: 10.1007/s12039-014-0670-4. [DOI] [Google Scholar]
  • 16.Cottam J., Livingstone R. 1226. 6,6-Diphenyl-6H-naphtho(2′,3′:2,3)pyran and 4,6-diphenyl-4H-naphtho(2′,3′:2,3)pyran. J. Chem. Soc. 1965:6646–6649. doi: 10.1039/JR9650006646. [DOI] [Google Scholar]
  • 17.Talley J.J. Synthesis of 4- and 6-Substituted 2,2-Dimethyl-2H-chromenes. Synthesis. 1983;10:845–847. doi: 10.1055/s-1983-30540. [DOI] [Google Scholar]
  • 18.North J.T., Kronenthal D.R., Pullockaran A.J., Real S.D., Chen H.Y. Synthesis of 6-cyano-2,2-dimethyl-2H-l-benzopyran and other substituted 2,2-dimethyl-2H-1–benzopyrans. J. Org. Chem. 1995;60:3397–3400. doi: 10.1021/jo00116a025. [DOI] [Google Scholar]
  • 19.Tiabi M., Zamarlik H. Synthese des pecocenes en une seule etape. Tetrahedron Lett. 1991;32:7251–7252. doi: 10.1016/0040-4039(91)80489-S. [DOI] [Google Scholar]
  • 20.Calderon-Higginson C., Crombie L., Redshaw S.D., Whiting D.A. Stereoselectivity, regioselectivity and mechanism in the intramolecular ’citran’bicyclisation of chromenes. J. Chem. Soc., Perkin. Trans. 2000;1:2491–2494. doi: 10.1039/b001310m. [DOI] [Google Scholar]
  • 21.Lamcharfi E., Menguy L., Zamarlik H. One-Pot Synthesis of Analogues of Precocenes and Isoprenyl-Chromenes. Synth. Commun. 1993;23:3019–3028. doi: 10.1080/00397919308011145. [DOI] [Google Scholar]
  • 22.Lee Y.R., Kim Y.M. A novel method for the synthesis of substituted benzochromenes by ethylenediamine diacetate-catalyzed cyclizations of naphthalenols to α, β-unsaturated aldehydes. concise synthesis of the natural products lapachenole, dihy-drolapachenole, and mollugin. Helv. Chim. Acta. 2007;90:2401–2413. [Google Scholar]
  • 23.Wang H., Rokita S.E. Dynamic Cross-Linking Is Retained in Duplex DNA after Multiple Exchange of Strands. Angew. Chem. Int. Ed. 2010;49:5957–5960. doi: 10.1002/anie.201001597. [DOI] [PubMed] [Google Scholar]
  • 24.Bai W.-J., David J.G., Feng Z.-G., Weaver M.G., Wu K.-L., Pettus T.R.R. The Domestication of ortho-Quinone Methides. Accounts Chem. Res. 2014;47:3655–3664. doi: 10.1021/ar500330x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Singh M.S., Nagaraju A., Anand N., Chowdhury S. ortho-Quinone methide (o-QM): a highly reactive, ephemeral and versatile intermediate in organic synthesis. RSC Adv. 2014;4:55924–55959. doi: 10.1039/C4RA11444B. [DOI] [Google Scholar]
  • 26.Willis N.J., Bray C.D. ortho-Quinone Methides in Natural Product Synthesis. Chem. Eur. J. 2012;18:9160–9173. doi: 10.1002/chem.201200619. [DOI] [PubMed] [Google Scholar]
  • 27.Pathak T.P., Sigman M.S. ChemInform Abstract: Applications of ortho-Quinone Methide Intermediates in Catalysis and Asymmetric Synthesis. Chemin. 2012;43 doi: 10.1002/chin.201206230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ferreira S.B., da Silva F.d.C., Pinto A.C., Gonzaga D.T.G., Ferreiraa V.F. Syntheses of Chromenes and Chromanes via o-Quinone Methide Intermediates. J. Heterocycl. Chem. 2009;46:1080–1097. doi: 10.1002/jhet.232. [DOI] [Google Scholar]
  • 29.Van De Water R.W., Pettus T.R.R. o-Quinone Methides: Intermediates Underdeveloped and Undertuilized in Organic Syn-thesis. Tetrahedron. 2002;58:5367–5405. doi: 10.1016/S0040-4020(02)00496-9. [DOI] [Google Scholar]
  • 30.Hong L., Wang L., Sun W., Wong K., Wang R. Organocatalytic asymmetric Friedel−Crafts alkylation/cyclization cascade reaction of 1-naphthols and α, β-unsaturated aldehydes: An enantioselective synthesis of chromanes and dihydrobenzopy-ranes. J. Org. Chem. 2009;74:6881–6884. doi: 10.1021/jo901409d. [DOI] [PubMed] [Google Scholar]
  • 31.Matsumoto J., Ishizu M., Kawano R., Hesaka D., Shiragami T., Hayashi Y., Yamashita T., Yasuda M. Generation of qui-none methide from aminomethyl(hydroxy)arenes precursors in aqueous solution. Tetrahedron. 2005;61:5735–5740. doi: 10.1016/j.tet.2005.04.037. [DOI] [Google Scholar]
  • 32.Huang P.-J.J., Cameron T.S., Jha A. Novel synthesis of 2, 2-dialkyl-3-dialkylamino-2, 3-dihydro-1H-naphtho [2, 1-b] pyrans. Tetrahedron Lett. 2009;50:51–54. doi: 10.1016/j.tetlet.2008.10.083. [DOI] [Google Scholar]
  • 33.Yu C.-G., Huang H., Li X.-M., Zhang Y.-T., Li H., Wang W. Anilines promoted cyclization-replacement cascade reactions of 2-hydroxycinnamaldehydes with various carbonic nucleophiles via in situ formed N, O-acetals. Chem. Eur. J. 2016;22:9240–9246. doi: 10.1002/chem.201601112. [DOI] [PubMed] [Google Scholar]
  • 34.Livingstone R., Whiting M.C. The structure of lapachenole, a hardwood extractive. J. Chem. Soc. 1955:3631–3636. doi: 10.1039/jr9550003631. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

Data of the compounds are available from the authors.


Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES